ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MT Pharma America's Radicava secures FDA approval to treat ALS
pharmaceutical-technology
May 10, 2017MT Pharma America has secured the US Food and Drug Administration (FDA) approval for Radicava (edaravone) as an intravenous infusion treatment for patients affected with amyotrophic lateral sclerosis (ALS). -
FDA approves drug to treat ALS
worldpharmanews
May 08, 2017The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease. -
Could Electromagnetic Fields Raise a Worker's ALS Risk?
drugs
March 30, 2017On-the-job exposure to electromagnetic fields may double the risk of developing amyotrophic lateral sclerosis (ALS), a degenerative disease of the nervous system, a new study suggests.
Pharma Sources Insight January 2025
